BioSyent is a life science company that acquires or licenses products, and commercializes these science-based technologies to advance human health and public safety. Co. owns and markets FeraMAX®, an oral hematinic to the Canadian healthcare market. FeraMAX® is indicated for the prevention and treatment of iron deficiency anaemia (IDA). Co. also manufactures and markets two products, namely Protect-It® and Insecolo. Protect-It® is a non-chemical, food-safe grain insecticide used as a preventative treatment against insect infestations in stored grains. Insecolo is a natural insecticide for home and garden use made from a patented formula of diatomaceous earth and food grade additives.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.